\-\ Texto\\:\\ \ \(0\)\
\-\ fetal\\ growth\\ parameters\\ corresponded\\ with\\ period\\ of\\ gestation\\ and\\ amniotic\\ fluid\\ was\\ adequate\\.\ \(0\)\
\-\ the\\ placenta\\ was\\ on\\ the\\ posterior\\ uterine\\ wall\\ and\\ showed\\ a\\ well\\-marginated\\,\\ hypoechoic\\ mass\\ measuring\\ 6\\ x\\ 6\\.4cm\\(fig\\.\\ 1\\)\\.\\ color\\ doppler\\ showed\\ increased\\ vascularity\\ of\\ the\\ mass\\,\\ in\\ the\\ central\\ and\\ peripheral\\ portions\\ \\(fig\\.\\ 2\\)\\.\\ only\\ arterial\\ flow\\ was\\ detected\\ \\(fig\\.\\ 3\\)\\.\\ umbilical\\ and\\ uterine\\ artery\\ flow\\ indices\\ were\\ normal\\.\\ follow\\-up\\ scan\\ after\\ four\\ weeks\\ showed\\ an\\ increase\\ in\\ the\\ size\\ of\\ the\\ mass\\,\\ which\\ now\\ measured\\ 9\\ x\\ 8\\ cm\\.\\ the\\ amniotic\\ fluid\\ was\\ slightly\\ increased\\ in\\ volume\\,\\ with\\ mild\\ iugr\\ and\\ mild\\ pericardial\\ effusion\\ \\(fig\\ 4\\)\\.\\ the\\ patient\\ went\\ into\\ premature\\ labor\\ at\\ 35\\ weeks\\ and\\ delivered\\ a\\ male\\ baby\\ weighing\\ 2\\.1\\ kg\\ by\\ cesarian\\ section\\.\\ \ \(0\)\
\-\ histopathological\\ examination\\ of\\ the\\ placenta\\ proved\\ the\\ mass\\ to\\ be\\ a\\ chorioangioma\\.\ \(0\)\
\-\ the\\ patient\\ went\\ into\\ premature\\ labor\\ at\\ 35\\ weeks\\ and\\ delivered\\ a\\ male\\ baby\\ weighing\\ 2\\.1\\ kg\\ by\\ cesarian\\ section\\.\ \(0\)\
\-\ \\ histopathological\\ examination\\ of\\ the\\ placenta\\ proved\\ the\\ mass\\ to\\ be\\ a\\ chorioangioma\\.\ \(0\)\
\-\ huge\\ hypoechoic\\ placental\\ mass\\ developped\\ at\\ the\\ fetal\\ surface\\ of\\ the\\ placental\\ disk\\ and\\ displaying\\ central\\ and\\ peripheral\\ vessels\\ \\ with\\ arterial\\ flow\\ characteristics\\.\ \(0\)\
\-\ giant\\ placental\\ chorioangioma\\ highly\\ suspected\\ by\\ color\\ doppler\\ study\\ and\\ confirmed\\ by\\ histopatholoic\\ examination\ \(0\)\
\-\ if\\ color\\ doppler\\ study\\ shows\\ vascularity\\ within\\ the\\ tumor\\ the\\ \\ differential\\ diagnosis\\ is\\ only\\ with\\ the\\ exceptional\\ arteriovenous\\ anastomosis\\.\ \(0\)\
\-\ if\\ \\ no\\ intratumoral\\ vascularity\\ \\ depicted\\ the\\ differential\\ diagnosis\\ is\\ with\\ \\:\ \(0\)\
\-\ \\ \\ \\-intrachorionic\\ \\ hematoma\ \(1\)\
\-\ \\ \\ \\-trophoblastic\\ cyst\ \(1\)\
\-\ \\ \\ \\-subamniotic\\ hematoma\ \(1\)\
\-\ \\ \\ \\-hydatiform\\ mole\ \(1\)\
\-\ a\\ twenty\\-six\\-years\\ old\\ female\\ third\\ gravida\\ \\ with\\ history\\ of\\ two\\ prior\\ caesarean\\ sections\\ was\\ referred\\ for\\ routine\\ antenatal\\ ultrasound\\ scan\\ at\\ 20\\ weeks\\ of\\ gestation\ \(0\)\
\-\ chorioangioma\\ is\\ a\\ primary\\ benign\\ tumor\\ with\\ predominantly\\ vascular\\ involvement\\.\\ it\\ is\\ found\\ in\\ 1\\%\\ of\\ all\\ placentas\\ undergoing\\ careful\\ and\\ systematic\\ histopathological\\ examination\\.\\ the\\ preferred\\ localisation\\ is\\ on\\ the\\ fetal\\ side\\ of\\ the\\ placental\\ disk\\ and\\ it\\ may\\ protrude\\ into\\ the\\ amniochorial\\ cavity\\;\\ the\\ volume\\ is\\ variable\\ \\(but\\ rarely\\ exceeds\\ a\\ maximum\\ diameter\\ of\\ 4\\-5\\ cm\\)\\.\\ \ \(0\)\
\-\ a\\ rarer\\ form\\ is\\ the\\ clinically\\ relevant\\ large\\ chorioangioma\\ which\\ is\\ likely\\ to\\ be\\ associated\\ with\\ complications\\ like\\ polyhydramnios\\,\\ pre\\-term\\ birth\\,\\ iugr\\,\\ anemia\\,\\ fetal\\ congested\\ heart\\ decompensation\\,\\ non\\-immune\\ fetal\\ hydrops\\,\\ perinatal\\ mortality\\.\\ \ \(0\)\
\-\ hydrops\\ fetalis\\ due\\ to\\ a\\ large\\ chorioangioma\\ is\\ a\\ rare\\ complication\\.\\ our\\ patient\\'s\\ fetus\\ had\\ only\\ pericardial\\ effusion\\ without\\ prominent\\ signs\\ of\\ fetal\\ hydrops\\.\\ \ \(0\)\
\-\ there\\ are\\ only\\ few\\ reports\\ of\\ color\\ and\\ pulse\\ doppler\\ assessment\\ of\\ placental\\ chorioangioma\\.\\ while\\ grundy\\ et\\ al\\ \\[1\\]\\ and\\ hirata\\ et\\ al\\ \\[2\\]\\ found\\ only\\ arterial\\ blood\\ flow\\ in\\ the\\ chorioangioma\\,\\ kung\\ et\\ al\\ \\[3\\]\\ did\\ not\\ find\\ any\\ vascularity\\ in\\ one\\ patient\\ and\\ only\\ peripheral\\ venous\\ flow\\ in\\ the\\ second\\.\\ our\\ study\\ showed\\ both\\ central\\ and\\ peripheral\\ flow\\ with\\ only\\ arterial\\ characteristics\\.\\ in\\ patients\\ with\\ fetal\\ and\\/or\\ maternal\\ complications\\,\\ color\\ doppler\\ may\\ play\\ a\\ role\\ in\\ demonstrating\\ the\\ blood\\ flow\\ inside\\ the\\ mass\\.\\ as\\ for\\ those\\ without\\ complications\\ and\\ with\\ little\\ or\\ no\\ blood\\ flow\\,\\ it\\ is\\ of\\ limited\\ use\\.\\ \ \(0\)\
\-\ with\\ the\\ increasing\\ use\\ of\\ ultrasound\\,\\ prenatal\\ diagnosis\\ of\\ these\\ tumors\\ is\\ becoming\\ more\\ common\\(4\\)\\.\ \(0\)\
\-\ management\\ includes\\ umblical\\ blood\\ sampling\\ and\\ intravascular\\ transfusion\\ for\\ fetal\\ anemia\\ which\\ temporarily\\ corrects\\ the\\ hydrops\\ and\\ significantly\\ prolongs\\ the\\ pregnancy\\(5\\)\\.\\ ablation\\ of\\ the\\ blood\\ supply\\ of\\ plancental\\ chorioangioma\\ via\\ operative\\ fetoscopy\\ is\\ another\\ management\\ alternative\\ in\\ patients\\ with\\ large\\ chorioangioma\\(5\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ chorioangioma\\:\\ 0\\.12671438645810162\ \(0\)\
\-\ fetal\\:\\ 0\\.05713773800081333\ \(0\)\
\-\ placental\\:\\ 0\\.054337387903368464\ \(0\)\
\-\ hydrops\\:\\ 0\\.04424352632043785\ \(0\)\
\-\ flow\\:\\ 0\\.03709758787334668\ \(0\)\
\-\ histopathological\\:\\ 0\\.035497933554346786\ \(0\)\
\-\ fig\\:\\ 0\\.034739953361906974\ \(0\)\
\-\ color\\:\\ 0\\.03424571038444274\ \(0\)\
\-\ doppler\\:\\ 0\\.033935855474895554\ \(0\)\
\-\ vascularity\\:\\ 0\\.03100935212968406\ \(0\)\
\-\ placenta\\:\\ 0\\.030425916720942067\ \(0\)\
\-\ only\\:\\ 0\\.029533467338907306\ \(0\)\
\-\ cesarian\\:\\ 0\\.026674454001335147\ \(0\)\
\-\ arterial\\:\\ 0\\.024567123866881254\ \(0\)\
\-\ iugr\\:\\ 0\\.024398108580777036\ \(0\)\
\-\ \\]\\:\\ 0\\.02202814286755081\ \(0\)\
\-\ \\[\\:\\ 0\\.021964579296930575\ \(0\)\
\-\ peripheral\\:\\ 0\\.02030826484081522\ \(0\)\
\-\ labor\\:\\ 0\\.01984541773966081\ \(0\)\
\-\ amniotic\\:\\ 0\\.019458609740789272\ \(0\)\
\-\ weighing\\:\\ 0\\.019458609740789272\ \(0\)\
\-\ blood\\:\\ 0\\.019149516194657632\ \(0\)\
\-\ 2\\.1\\:\\ 0\\.018952367770913216\ \(0\)\
\-\ showed\\:\\ 0\\.01840264872199472\ \(0\)\
\-\ proved\\:\\ 0\\.01837977865056912\ \(0\)\
\-\ kg\\:\\ 0\\.018127033031074446\ \(0\)\
\-\ delivered\\:\\ 0\\.017892356630476267\ \(0\)\
\-\ al\\:\\ 0\\.017845130901853634\ \(0\)\
\-\ examination\\:\\ 0\\.017447770347944598\ \(0\)\
\-\ et\\:\\ 0\\.017228563695183656\ \(0\)\
\-\ complications\\:\\ 0\\.016680654162620972\ \(0\)\
\-\ weeks\\:\\ 0\\.015929574757971417\ \(0\)\
\-\ gestation\\:\\ 0\\.01534444564064028\ \(0\)\
\-\ premature\\:\\ 0\\.015292726898544584\ \(0\)\
\-\ disk\\:\\ 0\\.015191670548243259\ \(0\)\
\-\ pericardial\\:\\ 0\\.015093631260395373\ \(0\)\
\-\ section\\:\\ 0\\.015045687748339042\ \(0\)\
\-\ went\\:\\ 0\\.014951850728818335\ \(0\)\
\-\ 6\\.4cm\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ developped\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ histopatholoic\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ \\-intrachorionic\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ \\-trophoblastic\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ \\-subamniotic\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ \\-hydatiform\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ twenty\\-six\\-years\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ placentas\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ localisation\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ amniochorial\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ grundy\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ hirata\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ kung\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ prolongs\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ plancental\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ fetoscopy\\:\\ 0\\.014475399710946631\ \(0\)\
\-\ uterine\\:\\ 0\\.014399676929796991\ \(0\)\
\-\ characteristics\\:\\ 0\\.013961150188829761\ \(0\)\
\-\ anemia\\:\\ 0\\.013961150188829761\ \(0\)\
\-\ central\\:\\ 0\\.013850400772709158\ \(0\)\
\-\ study\\:\\ 0\\.013850400772709158\ \(0\)\
\-\ baby\\:\\ 0\\.01366685738525115\ \(0\)\
\-\ mass\\:\\ 0\\.01366047134422488\ \(0\)\
\-\ our\\:\\ 0\\.013339665789360045\ \(0\)\
\-\ pre\\-term\\:\\ 0\\.013337227000667574\ \(0\)\
\-\ non\\-immune\\:\\ 0\\.013337227000667574\ \(0\)\
\-\ umblical\\:\\ 0\\.013337227000667574\ \(0\)\
\-\ volume\\:\\ 0\\.013255812580804495\ \(0\)\
\-\ 35\\:\\ 0\\.012915325127685147\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.012793226594871504\ \(0\)\
\-\ exceptional\\:\\ 0\\.01267143864581016\ \(0\)\
\-\ fetalis\\:\\ 0\\.01267143864581016\ \(0\)\
\-\ corrects\\:\\ 0\\.01267143864581016\ \(0\)\
\-\ displaying\\:\\ 0\\.012199054290388518\ \(0\)\
\-\ gravida\\:\\ 0\\.012199054290388518\ \(0\)\
\-\ rarer\\:\\ 0\\.011832644518115595\ \(0\)\
\-\ decompensation\\:\\ 0\\.011832644518115595\ \(0\)\
\-\ indices\\:\\ 0\\.011533265935531105\ \(0\)\
\-\ intratumoral\\:\\ 0\\.011533265935531105\ \(0\)\
\-\ caesarean\\:\\ 0\\.011533265935531105\ \(0\)\
\-\ protrude\\:\\ 0\\.011533265935531105\ \(0\)\
\-\ perinatal\\:\\ 0\\.011533265935531105\ \(0\)\
\-\ temporarily\\:\\ 0\\.011533265935531105\ \(0\)\
\-\ corresponded\\:\\ 0\\.011280144950593079\ \(0\)\
\-\ polyhydramnios\\:\\ 0\\.011280144950593079\ \(0\)\
\-\ use\\:\\ 0\\.011091754072391798\ \(0\)\
\-\ is\\:\\ 0\\.01107962124896011\ \(0\)\
\-\ well\\-marginated\\:\\ 0\\.011060881580109462\ \(0\)\
\-\ exceeds\\:\\ 0\\.011060881580109462\ \(0\)\
\-\ congested\\:\\ 0\\.011060881580109462\ \(0\)\
\-\ depicted\\:\\ 0\\.010867477580673692\ \(0\)\
\-\ mole\\:\\ 0\\.01069447180783654\ \(0\)\
\-\ antenatal\\:\\ 0\\.01069447180783654\ \(0\)\
\-\ systematic\\:\\ 0\\.01069447180783654\ \(0\)\
\-\ effusion\\:\\ 0\\.010663953760937279\ \(0\)\
\-\ management\\:\\ 0\\.010589594231381417\ \(0\)\
\-\ parameters\\:\\ 0\\.010395093225252049\ \(0\)\
\-\ relevant\\:\\ 0\\.010395093225252049\ \(0\)\
\-\ sampling\\:\\ 0\\.010395093225252049\ \(0\)\
\-\ huge\\:\\ 0\\.010263660207725716\ \(0\)\
\-\ 1\\:\\ 0\\.010016386049062596\ \(0\)\
\-\ into\\:\\ 0\\.010016386049062596\ \(0\)\
\-\ hematoma\\:\\ 0\\.009986754937346765\ \(0\)\
\-\ play\\:\\ 0\\.009922708869830404\ \(0\)\
\-\ becoming\\:\\ 0\\.0098231610507558\ \(0\)\
\-\ anastomosis\\:\\ 0\\.009729304870394636\ \(0\)\
\-\ diagnosis\\:\\ 0\\.009666105077736058\ \(0\)\
\-\ inside\\:\\ 0\\.009556299097557482\ \(0\)\
\-\ alternative\\:\\ 0\\.009556299097557482\ \(0\)\
\-\ \\(\\:\\ 0\\.009489152397292092\ \(0\)\
\-\ intravascular\\:\\ 0\\.009476183885456608\ \(0\)\
\-\ transfusion\\:\\ 0\\.009476183885456608\ \(0\)\
\-\ it\\:\\ 0\\.009462307312970526\ \(0\)\
\-\ \\)\\:\\ 0\\.009373237334821741\ \(0\)\
\-\ by\\:\\ 0\\.009345621696189653\ \(0\)\
\-\ sections\\:\\ 0\\.009326804939305992\ \(0\)\
\-\ 4\\-5\\:\\ 0\\.009326804939305992\ \(0\)\
\-\ x\\:\\ 0\\.009258017521666592\ \(0\)\
\-\ large\\:\\ 0\\.009204642521335368\ \(0\)\
\-\ find\\:\\ 0\\.00918988932528456\ \(0\)\
\-\ umbilical\\:\\ 0\\.00912548749744666\ \(0\)\
\-\ differential\\:\\ 0\\.008909556089828997\ \(0\)\
\-\ found\\:\\ 0\\.00884409068785587\ \(0\)\
\-\ maternal\\:\\ 0\\.0088366686690991\ \(0\)\
\-\ careful\\:\\ 0\\.008784536159551349\ \(0\)\
\-\ ablation\\:\\ 0\\.008784536159551349\ \(0\)\
\-\ preferred\\:\\ 0\\.008338011175177552\ \(0\)\
\-\ maximum\\:\\ 0\\.008338011175177552\ \(0\)\
\-\ ultrasound\\:\\ 0\\.008325525730726776\ \(0\)\
\-\ role\\:\\ 0\\.008299373248395624\ \(0\)\
\-\ 5\\:\\ 0\\.008210707462870816\ \(0\)\
\-\ fetus\\:\\ 0\\.008188632229026934\ \(0\)\
\-\ was\\:\\ 0\\.008113936963987578\ \(0\)\
\-\ fluid\\:\\ 0\\.007975826287697383\ \(0\)\
\-\ which\\:\\ 0\\.007857855109569205\ \(0\)\
\-\ scan\\:\\ 0\\.007856392316692868\ \(0\)\
\-\ 4\\:\\ 0\\.007819283760850722\ \(0\)\
\-\ a\\:\\ 0\\.00781477442007096\ \(0\)\
\-\ supply\\:\\ 0\\.007808005604959079\ \(0\)\
\-\ mortality\\:\\ 0\\.007646363449272292\ \(0\)\
\-\ measured\\:\\ 0\\.007620905014894681\ \(0\)\
\-\ little\\:\\ 0\\.007620905014894681\ \(0\)\
\-\ prenatal\\:\\ 0\\.007620905014894681\ \(0\)\
\-\ if\\:\\ 0\\.007614920964796832\ \(0\)\
\-\ at\\:\\ 0\\.007604355683623205\ \(0\)\
\-\ operative\\:\\ 0\\.007571142536248822\ \(0\)\
\-\ assessment\\:\\ 0\\.007546815630197687\ \(0\)\
\-\ cm\\:\\ 0\\.007526949483799625\ \(0\)\
\-\ adequate\\:\\ 0\\.007522843874169521\ \(0\)\
\-\ the\\:\\ 0\\.007491340550442777\ \(0\)\
\-\ variable\\:\\ 0\\.007475925364409167\ \(0\)\
\-\ detected\\:\\ 0\\.00740796934443732\ \(0\)\
\-\ mild\\:\\ 0\\.007389994922598151\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.00736417911934346\ \(0\)\
\-\ portions\\:\\ 0\\.00730060849178896\ \(0\)\
\-\ patients\\:\\ 0\\.0072629707696749615\ \(0\)\
\-\ pulse\\:\\ 0\\.0072394075151104185\ \(0\)\
\-\ significantly\\:\\ 0\\.007180405857924764\ \(0\)\
\-\ in\\:\\ 0\\.006919494747787438\ \(0\)\
\-\ undergoing\\:\\ 0\\.006881027275340274\ \(0\)\
\-\ complication\\:\\ 0\\.006881027275340274\ \(0\)\
\-\ increased\\:\\ 0\\.006865303060097391\ \(0\)\
\-\ giant\\:\\ 0\\.006757041146427063\ \(0\)\
\-\ highly\\:\\ 0\\.006757041146427063\ \(0\)\
\-\ birth\\:\\ 0\\.006742180989579909\ \(0\)\
\-\ rarely\\:\\ 0\\.006727454109476853\ \(0\)\
\-\ without\\:\\ 0\\.006607596605445518\ \(0\)\
\-\ predominantly\\:\\ 0\\.0065736191602530055\ \(0\)\
\-\ 3\\:\\ 0\\.006571348199364662\ \(0\)\
\-\ period\\:\\ 0\\.006560323248540987\ \(0\)\
\-\ form\\:\\ 0\\.006560323248540987\ \(0\)\
\-\ tumor\\:\\ 0\\.006542634816455866\ \(0\)\
\-\ like\\:\\ 0\\.006495412183259156\ \(0\)\
\-\ be\\:\\ 0\\.006491412430265661\ \(0\)\
\-\ those\\:\\ 0\\.006384671163890465\ \(0\)\
\-\ few\\:\\ 0\\.0063147867395574675\ \(0\)\
\-\ \\,\\:\\ 0\\.006223219896949135\ \(0\)\
\-\ surface\\:\\ 0\\.006193913476268065\ \(0\)\
\-\ may\\:\\ 0\\.0061554297829166625\ \(0\)\
\-\ clinically\\:\\ 0\\.006152075897777121\ \(0\)\
\-\ cavity\\:\\ 0\\.0061417809667203135\ \(0\)\
\-\ growth\\:\\ 0\\.006101234804831362\ \(0\)\
\-\ four\\:\\ 0\\.006091252791569651\ \(0\)\
\-\ demonstrating\\:\\ 0\\.006091252791569651\ \(0\)\
\-\ 2\\:\\ 0\\.006043036113335127\ \(0\)\
\-\ suspected\\:\\ 0\\.006042233147645708\ \(0\)\
\-\ pregnancy\\:\\ 0\\.006032602409628634\ \(0\)\
\-\ another\\:\\ 0\\.006032602409628634\ \(0\)\
\-\ via\\:\\ 0\\.006023027827837512\ \(0\)\
\-\ and\\/or\\:\\ 0\\.005930232737093108\ \(0\)\
\-\ limited\\:\\ 0\\.005921235256363017\ \(0\)\
\-\ diameter\\:\\ 0\\.005903386861885342\ \(0\)\
\-\ increase\\:\\ 0\\.005885730389346324\ \(0\)\
\-\ 9\\:\\ 0\\.005800188333708554\ \(0\)\
\-\ prominent\\:\\ 0\\.005759032391732829\ \(0\)\
\-\ increasing\\:\\ 0\\.0057509235548845825\ \(0\)\
\-\ slightly\\:\\ 0\\.005671964299272698\ \(0\)\
\-\ reports\\:\\ 0\\.00565661805556459\ \(0\)\
\-\ includes\\:\\ 0\\.00565661805556459\ \(0\)\
\-\ vessels\\:\\ 0\\.005648998384700054\ \(0\)\
\-\ third\\:\\ 0\\.005626349251477828\ \(0\)\
\-\ routine\\:\\ 0\\.005626349251477828\ \(0\)\
\-\ patient\\:\\ 0\\.005626219579089576\ \(0\)\
\-\ and\\:\\ 0\\.005616044513813055\ \(0\)\
\-\ measuring\\:\\ 0\\.005611421547534886\ \(0\)\
\-\ rare\\:\\ 0\\.005448850900941373\ \(0\)\
\-\ second\\:\\ 0\\.005389374277896515\ \(0\)\
\-\ referred\\:\\ 0\\.005294797115690708\ \(0\)\
\-\ confirmed\\:\\ 0\\.0052765182316696175\ \(0\)\
\-\ tumors\\:\\ 0\\.005270470209639575\ \(0\)\
\-\ 8\\:\\ 0\\.005246498453611409\ \(0\)\
\-\ involvement\\:\\ 0\\.005142756414824001\ \(0\)\
\-\ venous\\:\\ 0\\.005093244036875417\ \(0\)\
\-\ male\\:\\ 0\\.005074566626888253\ \(0\)\
\-\ did\\:\\ 0\\.005066368868625491\ \(0\)\
\-\ 20\\:\\ 0\\.005045181011752079\ \(0\)\
\-\ signs\\:\\ 0\\.004938219924443439\ \(0\)\
\-\ heart\\:\\ 0\\.004875336040901106\ \(0\)\
\-\ side\\:\\ 0\\.004861160101418836\ \(0\)\
\-\ benign\\:\\ 0\\.004842447236507719\ \(0\)\
\-\ now\\:\\ 0\\.004796577322991211\ \(0\)\
\-\ size\\:\\ 0\\.004704229673856767\ \(0\)\
\-\ vascular\\:\\ 0\\.00460066218049868\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.004564921168213041\ \(0\)\
\-\ any\\:\\ 0\\.0044184483301679695\ \(0\)\
\-\ while\\:\\ 0\\.0044148591787394305\ \(0\)\
\-\ 6\\:\\ 0\\.004190673499794539\ \(0\)\
\-\ artery\\:\\ 0\\.004178210167665351\ \(0\)\
\-\ primary\\:\\ 0\\.004156624405411652\ \(0\)\
\-\ wall\\:\\ 0\\.004064300690047202\ \(0\)\
\-\ two\\:\\ 0\\.004018606301504114\ \(0\)\
\-\ all\\:\\ 0\\.0039686756805111505\ \(0\)\
\-\ likely\\:\\ 0\\.003957783195296645\ \(0\)\
\-\ shows\\:\\ 0\\.003857756485597502\ \(0\)\
\-\ one\\:\\ 0\\.0038025145867169852\ \(0\)\
\-\ cyst\\:\\ 0\\.0037707243612908085\ \(0\)\
\-\ due\\:\\ 0\\.0037442974596926756\ \(0\)\
\-\ common\\:\\ 0\\.003672031546726432\ \(0\)\
\-\ these\\:\\ 0\\.0036516333201278162\ \(0\)\
\-\ of\\:\\ 0\\.00363476554213757\ \(0\)\
\-\ prior\\:\\ 0\\.003602812433829825\ \(0\)\
\-\ for\\:\\ 0\\.0035916657568606657\ \(0\)\
\-\ both\\:\\ 0\\.0035832512162333684\ \(0\)\
\-\ more\\:\\ 0\\.0035093207049460857\ \(0\)\
\-\ \\;\\:\\ 0\\.0033258147593638646\ \(0\)\
\-\ associated\\:\\ 0\\.0033111043709486074\ \(0\)\
\-\ \\%\\:\\ 0\\.003273105145067336\ \(0\)\
\-\ posterior\\:\\ 0\\.0032342176497577152\ \(0\)\
\-\ were\\:\\ 0\\.003186020257290511\ \(0\)\
\-\ \\'s\\:\\ 0\\.003093672608156067\ \(0\)\
\-\ had\\:\\ 0\\.0030276680118895044\ \(0\)\
\-\ but\\:\\ 0\\.0029926162578547415\ \(0\)\
\-\ after\\:\\ 0\\.0029031218433648643\ \(0\)\
\-\ female\\:\\ 0\\.002884663828321566\ \(0\)\
\-\ no\\:\\ 0\\.002825760757647954\ \(0\)\
\-\ to\\:\\ 0\\.002805045047244573\ \(0\)\
\-\ within\\:\\ 0\\.0026767346607324822\ \(0\)\
\-\ with\\:\\ 0\\.0024976260905887793\ \(0\)\
\-\ on\\:\\ 0\\.002377310385436545\ \(0\)\
\-\ normal\\:\\ 0\\.0021996920436766847\ \(0\)\
\-\ as\\:\\ 0\\.002122458958775251\ \(0\)\
\-\ there\\:\\ 0\\.0020882028841789635\ \(0\)\
\-\ not\\:\\ 0\\.0020276168665713224\ \(0\)\
\-\ an\\:\\ 0\\.0019403363945562065\ \(0\)\
\-\ history\\:\\ 0\\.0019379549059229612\ \(0\)\
\-\ are\\:\\ 0\\.0019127649795231555\ \(0\)\
\-\ \\:\\:\\ 0\\.0018559520788024055\ \(0\)\
\-\ \\.\\:\\ 0\\.0017487456205589299\ \(0\)\
\-\ or\\:\\ 0\\.0016445365336021469\ \(0\)\
\-\ old\\:\\ 0\\.0014366742148805493\ \(0\)\
